Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Plummer

Showing results (111-120 of 128) with videos related to

Pageof 13
Sort By:
Anesthesiology|April 30, 2020
Electroencephalogram Burst-suppression during Cardiopulmonary Bypass in Elderly Patients Mediates Postoperative DeliriumJuan C Pedemonte, George S Plummer, Shubham Chamadia, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2024
Durlobactam in combination with β-lactams to combat <i>Mycobacterium abscessus</i>Eunjeong Shin, Khalid M Dousa, Magdalena A Taracila, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
Potent and selective bicyclic lactam inhibitors of thrombin: Part 3: P1' modificationsJ S Plummer, K A Berryman, C Cai, et al.
Journal of Medicinal Chemistry|March 28, 1997
Structure-activity relationships in a series of orally active gamma-hydroxy butenolide endothelin antagonistsW C Patt, J J Edmunds, J T Repine, et al.
European Journal of Medicinal Chemistry|May 2, 2021
A γ-lactam siderophore antibiotic effective against multidrug-resistant Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter sppJoel A Goldberg, Vijay Kumar, Elizabeth J Spencer, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 2W L Cody, C E Augelli-Szafran, K A Berryman, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modificationsJ S Plummer, K A Berryman, C Cai, et al.
Genes, Chromosomes & Cancer|June 24, 1999
Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics ConsortiumK Laake, V Launonen, D Niederacher, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2013
Discovery of potent, selective, bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model, part I: transformation of selective pyrazolodiazepinone phosphodiesterase 4 (PDE4) inhibitors into selective PDE2 inhibitorsMark S Plummer, Joseph Cornicelli, Howard Roark, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2013
Discovery of potent selective bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model. Part II: optimization studies and demonstration of in vivo efficacyMark S Plummer, Joseph Cornicelli, Howard Roark, et al.
Pageof 13

Showing results (111-120 of 128) with videos related to

Sort By:
Pageof 13
Anesthesiology|April 30, 2020
Electroencephalogram Burst-suppression during Cardiopulmonary Bypass in Elderly Patients Mediates Postoperative DeliriumJuan C Pedemonte, George S Plummer, Shubham Chamadia, et al.
Antimicrobial Agents and Chemotherapy|December 23, 2024
Durlobactam in combination with β-lactams to combat <i>Mycobacterium abscessus</i>Eunjeong Shin, Khalid M Dousa, Magdalena A Taracila, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 1999
Potent and selective bicyclic lactam inhibitors of thrombin: Part 3: P1' modificationsJ S Plummer, K A Berryman, C Cai, et al.
Journal of Medicinal Chemistry|March 28, 1997
Structure-activity relationships in a series of orally active gamma-hydroxy butenolide endothelin antagonistsW C Patt, J J Edmunds, J T Repine, et al.
European Journal of Medicinal Chemistry|May 2, 2021
A γ-lactam siderophore antibiotic effective against multidrug-resistant Pseudomonas aeruginosa, Klebsiella pneumoniae, and Acinetobacter sppJoel A Goldberg, Vijay Kumar, Elizabeth J Spencer, et al.
Bioorganic & Medicinal Chemistry Letters|September 25, 1999
The design of potent and selective inhibitors of thrombin utilizing a piperazinedione template: part 2W L Cody, C E Augelli-Szafran, K A Berryman, et al.
Bioorganic & Medicinal Chemistry Letters|January 5, 1999
Potent and selective bicyclic lactam inhibitors of thrombin: Part 2: P1 modificationsJ S Plummer, K A Berryman, C Cai, et al.
Genes, Chromosomes & Cancer|June 24, 1999
Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics ConsortiumK Laake, V Launonen, D Niederacher, et al.
Bioorganic & Medicinal Chemistry Letters|April 16, 2013
Discovery of potent, selective, bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model, part I: transformation of selective pyrazolodiazepinone phosphodiesterase 4 (PDE4) inhibitors into selective PDE2 inhibitorsMark S Plummer, Joseph Cornicelli, Howard Roark, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2013
Discovery of potent selective bioavailable phosphodiesterase 2 (PDE2) inhibitors active in an osteoarthritis pain model. Part II: optimization studies and demonstration of in vivo efficacyMark S Plummer, Joseph Cornicelli, Howard Roark, et al.
Pageof 13